Managing stigma and disclosure of inflammatory bowel diseases for a good life with the disease. An interpretative phenomenological analysis study
Chronic Illness · 2026-06 · 22 (2) · 148-161
DOI: 10.1177/17423953261436465 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chronic Illness, online erschienen am 05.05.2026. Verfasst von Anke Erdmann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health, Kiel University of Applied Sciences, Moorblöcken 12, 24149 Kiel, Germany. Hauptthemen laut MEDLINE: Social Stigma, Inflammatory Bowel Diseases, Truth Disclosure, Disclosure. Die Arbeit nennt 35 Literaturangaben. Gefördert von: German Research Foundation, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Objectives
The aim of this study is to answer two research questions: 1. How do people with inflammatory bowel disease (IBD) disclose their condition to others? 2. How do non-affected people respond to disclosure of IBD? The findings complement our previous research with people suffering from IBD on their concepts of a ‘good life’.
Methods
We conducted 10 qualitative interviews with individuals with IBD and analyzed them with interpretative phenomenological analysis.
Results
Participants with IBD reported that non-affected people appear to have only marginal knowledge about this disease and they tend to trivialize the illness. They described stigmatizing responses which make them experience shame or lack of dignity. To deal with difficult responses, participants sometimes try to avoid embarrassing situations and limit the information they give others about their illness. Sometimes they break social relationships. They disclose their illness for strategic reasons, for example to generate understanding from their employers. But they also experience understanding from others after revealing their illness.
Discussion
Our study expands the evidence on experiences of stigma and the difficulties regarding disclosure in IBD, but also on the positive experiences of disclosure. Future research should focus on developing and evaluating appropriate methods for counseling on stigma and disclosure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Health, Kiel University of Applied Sciences, Moorblöcken 12, 24149 Kiel, Germany.
- Institute for History of Medicine and Science Studies, University of Lübeck, Königstr. 24, 23552 Lübeck, Germany.
- Institute of Clinical Molecular Biology (IKMB), Genetics & Bioinformatics Research Group, Kiel University, Rosalind-Franklin-Straße 12, 24105 Kiel, Germany.
- Institute for Ethics, History and Theory of Medicine, University of Münster, Von-Esmarch-Strasse 62, 48149 Münster, Germany.
ORCID-Profile: Anke Erdmann
Förderung
- German Research Foundation
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Erdmann, A., Rehmann-Sutter, C., Schrinner, F., & Bozzaro, C. (2026). Managing stigma and disclosure of inflammatory bowel diseases for a good life with the disease. An interpretative phenomenological analysis study. Chronic Illness, 22(2), 148-161. https://doi.org/10.1177/17423953261436465
Vancouver
Erdmann A, Rehmann-Sutter C, Schrinner F, Bozzaro C. Managing stigma and disclosure of inflammatory bowel diseases for a good life with the disease. An interpretative phenomenological analysis study. Chronic Illness. 2026;22(2):148-161. doi:10.1177/17423953261436465
BibTeX
@article{Erdmann2026,
author = {Erdmann, Anke and Rehmann-Sutter, Christoph and Schrinner, Florian and Bozzaro, Claudia},
title = {Managing stigma and disclosure of inflammatory bowel diseases for a good life with the disease. An interpretative phenomenological analysis study},
journal = {Chronic Illness},
year = {2026},
volume = {22},
number = {2},
pages = {148--161},
doi = {10.1177/17423953261436465}
}
EUVIMED